A Low-Copy Number Plasmid Mediating β-Lactamase Production by Xanthomonas Maltophilia

  • Michael D. Kelly
  • Joel E. Mortensen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 390)


Xanthomonas maltophilia has been isolated from river and well water, raw milk, rabbit feces, and frozen fish.6 This species is a common commensal, an occasional contaminant of clinical specimens, and part of the transient flora of hospitalized patients.5 Although it has been documented as a cause of bacteremia, urinary tract infections, respiratory tract infections, meningitis, serious wound infections, mastoiditis, epididymitis, conjunctivitis, and endocarditis, X. maltophilia is isolated predominantly from respiratory tract secretions.8,9,17,18


Infective Endocarditis Clavulanic Acid Plasmid Preparation Bethesda Research Laboratory Respiratory Tract Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. Alcova, G. Bonfiglio, and D.M. Livermore. Susceptibility to ß-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high and low level constitutive expression of L1 and L2 13-lactamases. J Med Microbiol 35: 4 208213, 1991.Google Scholar
  2. 2.
    H.C. Brinboim. A rapid alkaline extraction method for the isolation of plasmid DNA. Methods Enzymol 100: 243–255, 1983.CrossRefGoogle Scholar
  3. 3.
    A.P. Feinberg and B. Vogelstein. A technique for radiolabeling DNA restriction endonuclear fragments to high specific activity. Anal Biochem 132: 6, 1983.PubMedCrossRefGoogle Scholar
  4. 4.
    J.A. Garcia-Rodriguez and J.E. Garcia-Sanchez. Antibiotic susceptibility profile of Xanthomonas matlophilia. Diagn Microbiol Infect Dis 14: 239–243, 1991.PubMedCrossRefGoogle Scholar
  5. 5.
    G.L. Gilardi. Pseudomonas. In Manual of Clinical Microbiology. Fourth edition. Edited by E.H. Lennette, A. Balows, W.J. Hausler Jr, H.J. Shadomy. Washington D.C., American Society for Microbiology, 350–372, 1985.Google Scholar
  6. 6.
    R. Hugh and E. Ryschenkow. Pseudomonas maltophilia, an Alcaligenes-like species. J Gen Microbiol 26: 123–132, 1961.PubMedGoogle Scholar
  7. 7.
    S. Iyobe and S. Mitsuhashi. Genetics of R Factors in R Factor Drug Resistant Plasmid. Edited by S. Mitsuhashi, University of Tokyo Press, 49–71, 1977.Google Scholar
  8. 8.
    N. Khardori and Elting. Nosocomial infections clue to Xanthomonas maltophilia in patients with cancer. Rev Infect Dis 12: 6 997–1003, 1990.PubMedCrossRefGoogle Scholar
  9. 9.
    J.D. Klinger and M.J. Thomassen. Occurence and antimicrobial susceptibilities of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn Microbiol Infect Dis 3: 149–158, 1985.PubMedCrossRefGoogle Scholar
  10. 10.
    V. Krcmery, M. Antal, L. Langsadl, and H. Knothe. Transferable amikacin resistance in Pseudomonas maltophilia and Acinelobacter calcoaceltens (letter to the editor). Infection 13: 89–90, 1985.PubMedCrossRefGoogle Scholar
  11. 11.
    E. Lennon and B.J. DeCicco. Plasmids of Pseudomonas cepacia strains of diverse origins. Appt Enviornl Microbiol 57: 8 2345–2350, 1991.Google Scholar
  12. 12.
    H. Mett, S. Rosta, B. Schacher, and R. Frei. Outer membrane permeability and 13lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. Rev Infect Dis 10: 765–769, 1988.PubMedCrossRefGoogle Scholar
  13. 13.
    Y. Saino, M. Inoue, and S. Mitsuhashi. Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob Agents Chemother 25: 362–365, 1984.PubMedCrossRefGoogle Scholar
  14. 14.
    Y. Saino and F. Kobayashi. Inoue, M., M.tsuhashi, S. Purification and properties of inducible penicillin (3-lactamases isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother 22: 564–570, 1982.Google Scholar
  15. 15.
    J. Sambrook, E.F. Fritsch, and T. Maniatis. (eds) Molecular Cloning, A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989.Google Scholar
  16. 16.
    K. Timmis, I. Gonzalez-Carrero, and T. Sekizaki. Biological activities specified by antibiotic resistance plasmids. J Antimicrob Chemother 18:1–11, 1986 (suppl C).Google Scholar
  17. 17.
    V.L. Yu, L.W. Rumans, and W.J. Wing et aL Pseudomonas maltophilia causing heroin-associated infective endocarditis. Arch Intern Med 138: 1667–1671, 1978.PubMedCrossRefGoogle Scholar
  18. 18.
    J. Zuravleff and Y. Yu. Infections caused by Pseudomonas maltophilia with emphasis on Bacteremia: Case Reports and a review of the Literature. Rev Infect Dis 4: 6 1236–1246, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Michael D. Kelly
    • 1
    • 2
    • 3
  • Joel E. Mortensen
    • 1
    • 2
    • 3
  1. 1.Cardeza Foundation for Hematological ResearchThomas Jefferson UniversityPhiladelphiaUSA
  2. 2.Section of Infectious Diseases Department of Pediatrics Temple University School of MedicinePhiladelphiaUSA
  3. 3.Department of Laboratories St. Christopher’sHospital for ChildrenPhiladelphiaUSA

Personalised recommendations